Clinical Trials Directory

Trials / Completed

CompletedNCT00179556

Effects of Soy Isoflavones on Menopausal Hot Flashes

Daidzein-rich Isoflavone-aglycones for Menopausal Symptoms

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
210 (planned)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
Female
Age
38 Years – 65 Years
Healthy volunteers
Accepted

Summary

Hot flashes occur in three quarters of menopausal women, and can negatively impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The study examines the effect of a new soy supplement, as compared to a placebo, in menopausal women on hot flash symptoms.

Detailed description

Hot flashes occur in 75% of menopausal women and impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The effect of a daidzein-rich isoflavone-aglycone supplement from soy germ fermentation with Koji fungus, on the severity and frequency of hot flashes in postmenopausal women is being examined in a randomized, placebo controlled, double-blinded clinical trial. The study is a 13 week trial in which subjects record their hot flash frequency and severity in a diary. Subjects are given 40 mg or 60 mg of isoflavones (or placebo) once a day. This isoflavone-aglycone extract (Agly-Max TM, Nichimo, Shinagawa, Tokyo, Japan) is a product prepared from soybean germ fermentation with Koji fungus (Aspergliius awamori) producing ß-glycosidase efficiency, followed by ethanol and water extraction and purification by using a proprietary extraction procedure. The product is rich in daidzein (70% daidzein, 10% genistein, and 20% glycitein).

Conditions

Interventions

TypeNameDescription
DRUGIsoflavone supplement

Timeline

Start date
2003-06-01
Primary completion
2005-07-01
Completion
2005-09-01
First posted
2005-09-16
Last updated
2017-03-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00179556. Inclusion in this directory is not an endorsement.